We work with our partners of generic, specialty pharmaceutical, and biotechnical companies with diverse and huge portfolio of ANDAs, 505b(2) NDAs, new chemical entity (NCE) NDA, approved by FDA or in process of development. We are constantly looking for clients for licensing or co-marketing of these products.

Please contact us for your in- or out-license consultation, we will get back to you shortly.